IL-17 and IFN-gamma levels may be engaged in MIS-C inflammatory pathways due to the increase of CD4- and CD8- producing IL-17 in acute MIS-C patients and the decrease in convalescent MIS-C [22,23]. The gene discussed is CD8A; the disease is COVID-19–associated multisystem inflammatory syndrome in children.